Pharmaceutical
February 9, 2009
The Associated Press reports that two drugmakers-Eli Lily and Pfizer- spent hundreds of millions of dollars last year to raise awareness of a murky illness-fibromyalgia-helping boost sales of pills
Read More
February 4, 2009
King Pharmaceuticals Inc. has announced they will slash 22 percent of its jobs to reduce expenses, reported by the Associated Press. King will eliminate 520 jobs, including 380 sales positions
Read More
February 2, 2009
According to Reuters, GlaxoSmithKline is set to announce about 6,000 job losses when it posts results. The cuts by Glaxo, the world''s second largest drugs company after U.S. group
Read More
January 29, 2009
Doctors have long assumed that most antidepressants are interchangeable. But according to a new study reported by the Associated Press, Zoloft and Cipralex work slightly better than ten other popular
Read More
January 26, 2009
The Associated Press reports that Pfizer Inc. is buying rival drugmaker Wyeth in a $68 billion deal that will increase its revenue by 50 percent, solidify its No. 1 rank
Read More
January 20, 2009
The Associated Press reports that Pfizer Inc. plans to lay off nearly a third of its 8,000 salespeople. Company spokespeople declined to comment on a Wall Street Journal report that
Read More
January 14, 2009
Pfizer Inc., the world''s biggest drug company, is laying off up to 800 scientists this year in its latest effort to refocus disappointing research efforts and cut its massive overhead
Read More
January 12, 2009
Medical products and drug maker Abbott Laboratories is buying Advanced Medical Optics Inc. for about $1.36 billion plus debt to expand its eye-care offerings, including laser vision correction, as reported
Read More
January 7, 2009
The U.S. Patent & Trademark Office issued a notice allowing Pfizer to correct a technical defect in one of the patents involving Pfizer''s cholesterol medicine Lipitor, the world''s top-selling
Read More
January 5, 2009
Pfizer is willing to acquire a large rival drugs company to improve its financial health, in a move that could trigger a fresh round of mergers within the sector. Pfizer’s
Read More